Susan Shiff, Ph.D., is the president of Ontada where she leads the business in its vision of transforming the fight against cancer.
Susan is a well-respected leader in real-world data insights and has more than 25 years of healthcare experience. Prior to joining Ontada in 2021, she served as senior vice president of Merck & Co, Inc., where she was head of their Center for Observational and Real-World Evidence. She also helped to define the investment strategy for the $500MM Merck Global Health Innovation Fund, including new ventures with digital health companies. Susan started her career with the Centers for Disease Control and Prevention and has worked for life science leaders including Johnson & Johnson, Roche and Pfizer.
Susan holds an MBA from Cornell University and a Ph.D. from the University of California, Los Angeles.